sur OXURION (EBR:OXUR)
Oxurion reports transparency of Atlas Special Opportunities II LLC
Leuven, Belgium – On February 19, 2026, Oxurion NV, a company listed on Euronext Brussels, announced that it had received a transparency statement from Atlas Special Opportunities II LLC. According to this statement, as of February 16, 2026, Atlas held 3,458,157 Oxurion shares, representing a decrease below the 5% threshold of the total share capital of 70,098,394 shares following the sale of voting rights.
Oxurion, based in Leuven, specializes in acquiring majority stakes in promising European pharmaceutical contract manufacturers. The company aims to build an integrated group to serve the healthcare sector.
The statement also warns of the risks associated with planned investments in digital assets, such as Bitcoin and Ethereum, which could affect anticipated returns due to volatility and uncertain regulations.
R. P.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de OXURION